Open Accessibility Menu
Hide

Lung

Study Name: Beamon LUNG-2

  • Description: Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment
  • Study Number: 1479-0008
  • FHH or Referral: Referral
  • NCT#: NCT06151574
  • Cancer Stage: III or IV
  • Key Inclusion: Non-Squamous NSCLC; advanced or metastatic, HER2 mutation

Study Name: Destiny Lung 04

  • Description: A Study to Investigate the Efficacy and Safety of Trastuzumab Deruxtecan as the First Treatment Option for Unresectable, Locally Advanced/​Metastatic Non-Small Cell Lung Cancer With HER2 Mutations
  • Study Number: D967SC00001
  • FHH or Referral: Referral
  • NCT#: NCT05048797
  • Cancer Stage: III or IV
  • Key Inclusion: Non-Squamous NSCLC; HER2+ in exons 19 or 20

Study Name: Henlius

  • Description: A Study to Evaluate the Efficacy and Safety of Serplulimab in Combination With Chemotherapy and Concurrent Radiotherapy in Patients With Limited-Stage Small Cell Lung Cancer
  • Study Number: HLX10-020-SCLC302
  • FHH or Referral: Referral
  • NCT#: NCT05353257
  • Cancer Stage: I-III
  • Key Inclusion: LS-SCLC; treatment naïve

For more information , call XXX

All Locations